Novopyxis

Novopyxis is a biotechnology company developing novel anti-inflammatory therapies and interventions, founded in 2013 by several scientists, engineers, and mathematicians from MIT. The company's current research focus is on treating neurological and metabolic diseases caused by ALS and cystic fibrosis.